Cleveland Clinic Rheumatology

Cleveland Clinic offers expert diagnosis, treatment and rehabilitation for bone, joint or connective tissue disorders and rheumatic and immunologic diseases.

 

Cleveland Clinic Rheumatology
Avatar

SLE With High Disease Activity & Potential Therapeutic Targets: Should LDA Be the Endpoint in Clinical Studies? Is Bimekizumab Safe and Effective in Ankylosing Spondylitis?

By Cleveland Clinic Rheumatology FEATURING Arthur Kavanaugh, John J. Cush
By Cleveland Clinic Rheumatology FEATURING Arthur Kavanaugh, John J. Cush
19 views
September 3, 2020
0 Comments
Login to view comments. Click here to Login
SLE
36:47
Cleveland Clinic Rheumatology

SLE Management: What Are the New Agents That Have Been Approved or H…

Feat. J. Looney
23:26
Cleveland Clinic Rheumatology

SLE: New Perspectives on Pathogenesis and Emerging Novel Therapies

Feat. G. Silverman
07:48
Cleveland Clinic Rheumatology

Eye Disorders in Rheumatic Diseases: What Are the Recommendations on…

Feat. J. Rosenbaum
09:50
Cleveland Clinic Rheumatology

SLE With High Disease Activity & Potential Therapeutic Targets: …

Feat. A. Kavanaugh, J. Cush
08:35
Cleveland Clinic Rheumatology

Managing Dermatologic Conditions in Rheumatology: How to Recognize a…

Feat. A. Fernandez
16:25
Cleveland Clinic Rheumatology

Advances in the Laboratory Aspects of Basic and Clinical Immunology …

Feat. W. Rigby
34:21
Cleveland Clinic Rheumatology

A Primer on the Microbiome and Immune Health and Disease

Feat. G. Silverman
65:29
Cleveland Clinic Rheumatology

Immunology for the Non-Immunologist: Understanding Immunology When Y…

Feat. L. Calabrese
Cleveland Clinic Rheumatology

Understanding B and T Cell Targeting in Autoimmune Diseases: Is Beli…

Feat. G. Silverman
32:03
Cleveland Clinic Rheumatology

New and Emerging Treatments of Cutaneous Lupus

Feat. J. Merola
36:22
Cleveland Clinic Rheumatology

Advances in SLE and Vasculitis

Feat. G. Silverman
18:28
Cleveland Clinic Rheumatology

Kinase Inhibition for IMIDs

Feat. W. Rigby